Jagsonpal Pharmaceuticals Share Price
Small Cap | Pharmaceuticals and health care | NSE: JAGSNPHARM | BSE: 507789
₹204.60 
-4.60 (-2.20 %)
Last Updated: 13 Mar 2025 12:00 AM
BEARISH
Overview
Open (₹) 210.00
High (₹) 211.45
Low (₹) 202.70
Prev. Close (₹) 209.20
Volume 8,210
VWAP (₹) 206.36
ROCE (%) 15.50
Industry P/E 43.95
TTM P/E 25.96
P/B Ratio 2.89
Market Cap (₹) Cr.1,360.67
Dividend Yield (%)2.44
EPS (₹) 8.46
ROE11.94%
Sales Growth (%) -11.83
Profit Growth (%)-15.94
Day Range
211.45211.45
52 Week Range
108.02328.02
Historical Returns
Returns (6M)
24.91 %
Returns (1Y)
72.31 %
Returns (3Y)
107.42 %
Returns (5Y)
2444.78 %
Returns (6M)
24.91 %
Returns (1Y)
72.31 %
Returns (3Y)
107.42 %
Returns (5Y)
2444.78 %
SWOT Analysis
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
Technicals
Technical Rating
BEARISHRSI 36.89
MFI 38.41
ATR 17.99
Commodity Channel Index -106.89
ROC125 28.24
ROC21 -17.20
Williams %R -94.13
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 210.50 | 214.50 | 218.65 | 206.35 | 202.35 | 198.20 | 194.20 |
| Week Ago | 226.01 | 232.58 | 237.06 | 221.53 | 214.96 | 210.48 | 203.91 |
| Month Ago | 237.50 | 252.30 | 271.05 | 218.75 | 203.95 | 185.20 | 170.40 |
EMA & SMA
204.60
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
18
5 Day 215.50
9 Day 216.36
10 Day 219.12
12 Day 219.89
14 Day 224.11
20 Day 234.06
26 Day 234.44
50 Day 240.10
100 Day 232.87
200 Day 190.30
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| ORION STOCKS LTD | bulk | Sell | 27 May, 2021 | ₹102.20 | 64,674 | BSE |
| ORION STOCKS LTD | bulk | Buy | 27 May, 2021 | ₹100.98 | 1,35,114 | BSE |
| ORION STOCKS LTD | bulk | Sell | 25 Mar, 2021 | ₹81.35 | 1,07,088 | BSE |
| ORION STOCKS LTD | bulk | Buy | 25 Mar, 2021 | ₹79.67 | 1,44,875 | BSE |
| ORION STOCKS LTD | bulk | Sell | 24 Mar, 2021 | ₹83.25 | 1,44,903 | BSE |
| ORION STOCKS LTD | bulk | Buy | 24 Mar, 2021 | ₹81.52 | 1,80,401 | BSE |
| ORION STOCKS LTD | bulk | Sell | 22 Mar, 2021 | ₹80.08 | 1,16,406 | BSE |
| ORION STOCKS LTD | bulk | Buy | 22 Mar, 2021 | ₹78.49 | 1,53,393 | BSE |
| ORION STOCKS LTD | bulk | Sell | 19 Mar, 2021 | ₹78.06 | 1,34,220 | BSE |
| ORION STOCKS LTD | bulk | Buy | 19 Mar, 2021 | ₹77.20 | 1,16,562 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 29 Jun, 2022 | Rajpal Singh Kochhar for and on behalf of Aresko Progressive Private Limited acting in capacity as a trustee of the Aresko Progressive Trust; and as the representative partner of J&P Investments Partnership | Disposal | ₹235.00 | 1,14,55,500 | BSE |
| 28 Feb, 2022 | Rajpal Singh Kochhar for and on behalf of Aresko Progressive Private Limited acting in capacity as a trustee of the Aresko Progressive Trust; and as the representative partner of J&P Investments Partnership | Disposal | ₹238.12 | 2,25,737 | BSE |
| 25 Feb, 2022 | Rajpal Singh Kochhar for and on behalf of Aresko Progressive Private Limited acting in capacity as a trustee of the Aresko Progressive Trust; and as the representative partner of J&P Investments Partnership | Disposal | ₹234.15 | 1,99,763 | BSE |
| 04 Jan, 2021 | INDERPAL SINGH KOCHHAR | Acquisition | ₹72.06 | 17,642 | BSE |
| 24 Dec, 2020 | INDERPAL SINGH KOCHHAR | Acquisition | ₹67.12 | 3,000 | BSE |
| 23 Dec, 2020 | INDERPAL SINGH KOCHHAR | Acquisition | ₹67.06 | 15,752 | BSE |
| 21 Dec, 2020 | INDERPAL SINGH KOCHHAR | Acquisition | ₹69.87 | 5,625 | BSE |
| 18 Dec, 2020 | INDERPAL SINGH KOCHHAR | Acquisition | ₹69.12 | 3,366 | BSE |
| 15 Dec, 2020 | INDERPAL SINGH KOCHHAR | Acquisition | ₹66.84 | 6,000 | BSE |
| 15 Dec, 2020 | INDERPAL SINGH KOCHHAR | Acquisition | ₹67.62 | 3,000 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 23 Oct, 2024 | Stock split from Rs. 5/- to Rs. 2/-. | 08 Jan, 2025 | 08 Jan, 2025 |
| 21 May, 2024 | Rs.5.0000 per share(100%)Final Dividend | 06 Sept, 2024 | 06 Sept, 2024 |
| 23 May, 2023 | Rs.5.0000 per share(100%)Dividend | 21 Aug, 2023 | 21 Aug, 2023 |
| 19 Oct, 2021 | Rs.4.0000 per share(80%)Interim Dividend | 29 Oct, 2021 | 01 Nov, 2021 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 13 Mar, 2025 | NSE India | JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange regarding Allotment of Securities |
| 13 Mar, 2025 | NSE India | JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
| 13 Mar, 2025 | NSE India | Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding ''Allotment of Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022 ( JPL ESOP 2022 )''. |
| 13 Mar, 2025 | BSE India | Allotment of Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022 |
| 13 Mar, 2025 | NSE India | Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding ''Intimation under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations)''. |
| 13 Mar, 2025 | BSE India | We wish to inform you that consequent to the appointment of Mr. Pratham Rawal as Company Secretary, the board of directors have approved changes in KMPs authorized for purpose of determining materiality of an event or information and for the purpose of making disclosures to stock exchange (s) under the Listing Regulations. |
| 13 Mar, 2025 | NSE India | Jagsonpal Pharmaceuticals Limited has informed the Exchange about Change in Company Secretary/Compliance Officer |
| 13 Mar, 2025 | BSE India | Appointment of Mr. Pratham Rawal as Company Secretary and Compliance Officer of the Company w.e.f. March 13, 2025 |
| 03 Mar, 2025 | NSE India | JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
| 03 Mar, 2025 | NSE India | Jagsonpal Pharmaceuticals Limited has informed the Exchange about Change in Company Secretary/Compliance Officer |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 16 Jan, 2025 | 22 Jan, 2025 |
| Quarterly Results & Stock Split | -- | 17 Oct, 2024 | 23 Oct, 2024 |
| Quarterly Results | -- | 01 Aug, 2024 | 07 Aug, 2024 |
| Audited Results & Final Dividend | -- | 14 May, 2024 | 20 May, 2024 |
| Quarterly Results | -- | 30 Jan, 2024 | 02 Feb, 2024 |
| Quarterly Results | -- | 27 Oct, 2023 | 03 Nov, 2023 |
| Quarterly Results | -- | 27 Jul, 2023 | 02 Aug, 2023 |
| Audited Results & Dividend | -- | 16 May, 2023 | 23 May, 2023 |
| Quarterly Results | -- | 01 Feb, 2023 | 08 Feb, 2023 |
| Quarterly Results | -- | 04 Nov, 2022 | 09 Nov, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Jagsonpal Pharmaceuticals
Jagsonpal Pharmaceuticals is a Public Limited Listed company incorporated on 17/08/1978 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1978PLC009181 and registration number is 009181. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 208.70 Cr. and Equity Capital is Rs. 13.22 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1978
Managing Director
Mr. Manish Gupta
NSE Symbol
JAGSNPHARM
Jagsonpal Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Rajpal Singh Kochhar | Chairman Emeritus |
| Mr. Harsha Raghavan | Chairman & Non-Exe.Director |
| Mr. Manish Gupta | Managing Director |
| Mr. Prithipal Singh Kochhar | Non Executive Director |
| Mr. Debasis Bikash Nandy | Independent Director |
| Ms. Radhika Madhukar Dudhat | Independent Director |
| Ms. Pallavi Dinodia Gupta | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45  ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45  ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
| Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Jagsonpal Pharmaceuticals
What is the share price of Jagsonpal Pharmaceuticals?
The share price of Jagsonpal Pharmaceuticals on 13 Mar, 2025 is ₹ 204.60.
What is 52W high and 52W low share price of Jagsonpal Pharmaceuticals?
The highest and lowest 52W share prices of Jagsonpal Pharmaceuticals are ₹ 328.020 and ₹ 108.020
What is the market cap of Jagsonpal Pharmaceuticals?
The market capitalization of Jagsonpal Pharmaceuticals as of 13 Mar, 2025 is ₹ 1,360.67 Crores
What is the P/E ratio of Jagsonpal Pharmaceuticals?
The current P/E ratio of Jagsonpal Pharmaceuticals as of 13 Mar, 2025 is 43.95
What is the PB ratio of Jagsonpal Pharmaceuticals?
The PB ratio of Jagsonpal Pharmaceuticals as of 13 Mar, 2025 is 2.89
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)